Home » Authors » Mark Lawson

Mark Lawson

Articles

ARTICLES

Court Documents Reveal GSK's Stand On Relenza

June 15, 2005

Court Documents Reveal GSK's Stand On Relenza

June 15, 2005

Investor Interest Wanes For Australia's Biotech Stocks

April 20, 2005

Investor Interest Wanes For Australia's Biotech Stocks

April 20, 2005

Australian Stock Exchange: Commissioned Reports OK

Feb. 9, 2005

Australian Stock Exchange: Commissioned Reports OK

Feb. 9, 2005

Metabolic Jumps, Slides On Trial Data, Analyst Criticism

Dec. 22, 2004

Metabolic Jumps, Slides On Trial Data, Analyst Criticism

Dec. 22, 2004

Peptech, J&J Unit Centocor Settle Remicade IP Dispute

Nov. 24, 2004

Peptech, J&J Unit Centocor Settle Remicade IP Dispute

Nov. 24, 2004

View All Articles by Mark Lawson

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.